Sequential NIPPV + IMT treatment markedly alleviated dyspnea COPD patients
dyspnea COPD, dyspnea, COPD
COPD
The efficacy of sequential NIPPV + IMT treatment for dyspnea in patients with COPD were evaluated by MRC scale. After 8 weeks of treatment, the MRC score was strikingly reduced in patients in NIPPV, IMT and sequential NIPPV + IMT groups compared that in OT group (Fig. 
Sequential NIPPV + IMT treatment markedly alleviated dyspnea COPD patients. A total of 100 COPD patients were enrolled and randomly divided into OT group, NIPPV group, IMT group and NIPPV + IMT group. After 8 weeks of treatment, dyspnea in patients with COPD were evaluated by MRC scale. *P < 0.05, **P < 0.01, ***P < 0.001